(PharmaNewsWire.Com, May 16, 2017 ) According to the report, North America Liquid Biopsy Market published by Market Data Forecast, the North American market has been estimated at $177.06 million in 2016 and is projected to reach $433.29 million with CAGR of 19.6% in the forecast period 2016-2021.
Technological advances over the past two decades have improved the treatment of cancer patient owing to liquid biopsy. Liquid biopsies also present with a unique opportunity to move forward with the understanding of metastatic disease development, especially to identify the pathways involved in cell invasiveness and metastatic competence.
North America is leading market for Liquid Biopsy. Liquid biopsy market is soaring high in North America as colorectal cancer is one of the most common cancers diagnosed in North American region. There is a lot of research going on for the detection of colorectal cancer. Liquid biopsy is more effective than tissue biopsy as they can be performed with less complication and in an easy manner and they provide more accurate results.
Increase in the geriatric population and increasing number of cancer patient, technological innovation in the region and availability of funds are the driving factors in North American region for the growth of market. Also due to increase in number of cancer patient, public awareness has increased regarding treatment and prevention of these diseases which has also led to growth of this market.
Segmentation By Type Lung Cancer. Pancreatic Cancer. Leukemia. Other Visceral Cancers.
By Diagnostic Approach Circulating Tumor cells (CTC). Circulating Tumor DNA. RNA in exosomes. Extra-Cellular Vesicles.
By End Users Reference laboratories Hospital/physician laboratories. Academic and Research Centers. Others.
By Sample Type Blood. Urine. Plasma. Saliva. Cerebrospinal fluid.
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
The North America Liquid Biopsy Market study offers following deliverables:
Global Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout other related studies in the Diagnostic Segment:
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
